Prefilled Syringes Market Worth $6.36 Billion | Benefits to Healthcare Professionals & Rising Adoption of Self-Injection Devices

PUNE, India, 2020-May-27 — /EPR Network/ —

[130 Pages Report] The Prefilled Syringes Market is expected to reach USD 6.36 Billion, at a CAGR of 10.1% during the forecast period.

The rising demand for prefilled syringes can be attributed to the growing prevalence of chronic diseases, technological advancements, rising adoption of self-injecting parenteral devices, and implementation of needlestick legislations.

Development of technologically advanced prefilled syringes and growing adoption of self-injection devices are the major trends in the prefilled syringes. Key players in the prefilled syringes market are focusing on expanding their product portfolio with technologically advanced products in order to cater to the growing demand of these devices across the globe.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=16618331

This report broadly segments the global prefilled syringes market into materials, types and design.

On the basis of material, the market is segmented into glass prefilled syringes and plastic prefilled syringes. The glass prefilled syringes segment is expected to account for the largest of the market in 2016. The growth of this segment can be attributed to the high use of glass in manufacturing syringes owing to its nonreactive nature and heat and chemical resistance.

On the basis of type, the market is categorized into conventional prefilled syringes and safety prefilled syringes. The conventional prefilled syringes segment is expected to account for the largest share of the market in 2016. The increasing adoption of self-administered injectable drugs, rising prevalence of chronic diseases, and the benefits offered by prefilled syringes over traditional vial syringe systems are the key factors responsible for the growth of this segment.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=16618331

On the basis of region, the market is segmented into four regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World. Europe is estimated to dominate the global market. Factors such as the rising prevalence of chronic diseases, growth in the biologics and biosimilars market, technological advancements, geographical expansion by key manufacturers, rising aging population, and high adoption of self-injection devices are driving the growth in the European market. The Asia-Pacific market is expected to grow at the highest CAGR during the forecast period.

Expansions and product launches were the primary growth strategies adopted by major players to expand their product portfolio in the global prefilled syringes market. Several market players also adopted strategies such as acquisitions and partnerships to expand their presence and increase their visibility in the market. Becton, Dickinson and Company (U.S.), Gerresheimer AG (Germany), SCHOTT AG (Germany), West Pharmaceutical Services, Inc. (U.S.), Ompi (Italy), Catalent, Inc. (U.S.), Weigao Group (China), Vetter Pharma International GmbH (Germany). Nipro Corporation (Japan), and MedPro Inc. (U.S.) are some of the key players operating in the global market.